Kenvue Inc. (KVUE) Q3 2026 Earnings Call

Concluded Oct 30, 2026

Oct 30, 2026

Revenue $3.89B +3.2% YoY

Diluted EPS $0.22 +4.8% YoY

Gross margin 59.5% +0.4 pp YoY

Net income $430.00M +8% YoY

Executive readout · one minute

What the filings say

8-K earnings release · filed Oct 30, 2026: Kenvue Inc. reported fiscal third-quarter net sales growth of 3.2%, organic sales growth of 2.9% and diluted EPS of $0.22 for the period ended September 27, 2026. Free cash flow for fiscal nine months rose to $1.6 billion from $1.0 billion.
10-Q report · filed Oct 30, 2026: Kenvue reported nine-month net sales of $11.8 billion, up 3.6%, for the fiscal period ended September 27, 2026. Shareholders approved the pending K-C acquisition, with each Kenvue share receiving 0.14625 K-C shares and $3.50 in cash.

The audio replay and transcript follow the call.

Forward guidance

1 guided metrics

Management's latest ranges and targets are included below.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed Oct 30, 2026 10-Q report Filed Oct 30, 2026 Company webcastOpen the original investor-relations page

From the 8-K filed Oct 30, 2026.

Metric	Period	Guided	Basis
Pre-tax restructuring expenses and other charges Initiated fiscal year 2026	fiscal year 2026	$250M	—

How the reported period landed and where the business moved.

Self Care$1.66B +5.9% YoY

Essential Health$1.19B +2.5% YoY

Skin Health and Beauty$1.04B +0.1% YoY